Dr. Reddy's Laboratories launches Difluprednate Ophthalmic Emulsion 0.05% in US
The Durezol brand and generic had US sales of approximately US $40 million MAT for the most recent twelve months ending in Nov 2022 according to IQVIA
The Durezol brand and generic had US sales of approximately US $40 million MAT for the most recent twelve months ending in Nov 2022 according to IQVIA
Results showed a statistically significant and clinically meaningful improvement in investigator-assessed progression-free survival
The company's long-term strategy is on science, technology and innovation and the company's strategy relating to this is on track
Since FY 2020 till FY 2022, the organisation has reduced energy consumption by 9.2%
Amongst the first pharmaceutical companies in India and Asia to be recognised for adopting advanced fourth industrial revolution technologies to digitally transform operations
Dr. Reddy’s largest manufacturing facility in Bachupally, Hyderabad, joins Global Lighthouse Network of the World Economic Forum
This recognition marks the third time in five years that Merck has been included on Fortune’s Change the World list.
The award was presented to Biocon Foundation as a mark of recognition of various projects undertaken during the year for reducing the environmental impact on cities
Transformation to pure-play Innovative Medicines company nears completion
We are launching the five new products in the new manufacturing facility and they're all pharmaceuticals and this should lead to an increase in pharma numbers.
Subscribe To Our Newsletter & Stay Updated